Literature DB >> 11763280

Cross cultural differences in health related quality of life in adolescents with cystic fibrosis.

J Abbott1, U Baumann, S Conway, C Etherington, L Gee, J M Von Der Schulenburg, K Webb.   

Abstract

PURPOSE: Quality of Life (QoL) is an important outcome measure in health care and pharmacological trials. The trend towards multinational clinical trials may be problematic because it is unclear as to whether, or to what extent, QoL-measures are comparable across cultures. This study compared QoL between English and German adolescents with Cystic Fibrosis (CF) and their healthy peers.
METHOD: The study comprised a cross-sectional design. The English subjects formed two groups; 58 adolescents with CF and 49 healthy controls. The German subjects consisted of 26 adolescents with CF and 75 healthy controls. Quality of life was measured using the English and German versions of the SF-36. Demographic (age and gender) and clinical data (FEV1% predicted and BMI) were also recorded.
RESULTS: The English and German CF groups had similar age-adjusted lung function and body mass index. Both the English CF and control groups reported a poorer quality of life than their respective German counterparts across several domains of the SF-36. These were limitations in activities due to physical health problems and emotional difficulties, social functioning, energy and vitality and pain.
CONCLUSIONS: The differences in quality of life between English and German adolescents with CF appear to be either culturally determined or due to idiosyncrasies in the translations of the SF-36. rather than a consequence of their disease or its management.

Entities:  

Mesh:

Year:  2001        PMID: 11763280     DOI: 10.1080/09638280110072913

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  4 in total

Review 1.  Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.

Authors:  Janice Abbott; Louise Gee
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

2.  Validation and test-retest reliability of the Royal Free Interview for Spiritual and Religious Beliefs when adapted to a Greek population.

Authors:  Despina Sapountzi-Krepia; Vasilios Raftopoulos; Marcos Sgantzos; Evangelia Kotrotsiou; Zoe Roupa-Darivaki; Kalliope Sotiropoulou; Ioanna Ntourou; Alexandra Dimitriadou
Journal:  Ann Gen Psychiatry       Date:  2005-03-04       Impact factor: 3.455

3.  Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R.

Authors:  Anne Schmidt; Kerstin Wenninger; Nadja Niemann; Ulrich Wahn; Doris Staab
Journal:  Health Qual Life Outcomes       Date:  2009-12-02       Impact factor: 3.186

4.  Psychometric evaluation of the Swedish translation of the revised Cystic Fibrosis Questionnaire in adults.

Authors:  Jacek Hochwälder; Agneta Bergsten Brucefors; Lena Hjelte
Journal:  Ups J Med Sci       Date:  2016-09-15       Impact factor: 2.384

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.